These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38241003)

  • 1. Physio-chemical Modifications to Re-engineer Small Extracellular Vesicles for Targeted Anticancer Therapeutics Delivery and Imaging.
    Asfiya R; Xu L; Paramanantham A; Kabytaev K; Chernatynskaya A; McCully G; Yang H; Srivastava A
    ACS Biomater Sci Eng; 2024 Feb; 10(2):697-722. PubMed ID: 38241003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy.
    Liu X; Xiao C; Xiao K
    J Nanobiotechnology; 2023 Aug; 21(1):287. PubMed ID: 37608298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Trends in the Use of Small Extracellular Vesicles as Optimal Drug Delivery Vehicles in Oncology.
    Kumar SK; Sasidhar MV
    Mol Pharm; 2023 Aug; 20(8):3829-3842. PubMed ID: 37410017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple approach to re-engineering small extracellular vesicles to circumvent endosome entrapment.
    Geng T; Tang M; Yee Paek S; Leung E; Chamley LW; Wu Z
    Int J Pharm; 2022 Oct; 626():122153. PubMed ID: 36055444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Roles of Using Small Extracellular Vesicles as an Anti-Cancer Drug.
    Joo HS; Suh JH; So CM; Jeon HJ; Yoon SH; Lee JM
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical Progress.
    Goo J; Lee Y; Lee J; Kim IS; Jeong C
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Application of Small Extracellular Vesicles (sEVs): Pharmaceutical and Pharmacokinetic Challenges.
    Takakura Y; Matsumoto A; Takahashi Y
    Biol Pharm Bull; 2020; 43(4):576-583. PubMed ID: 32238700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: Milk Small Extracellular Vesicles for Use in the Delivery of Therapeutics.
    Munir J; Ngu A; Wang H; Ramirez DMO; Zempleni J
    Pharm Res; 2023 Apr; 40(4):909-915. PubMed ID: 36198923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.
    Geng T; Pan P; Leung E; Chen Q; Chamley L; Wu Z
    Pharm Res; 2021 Feb; 38(2):179-197. PubMed ID: 33604783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral Graphene Quantum Dots Enhanced Drug Loading into Small Extracellular Vesicles.
    Zhang Y; Kim G; Zhu Y; Wang C; Zhu R; Lu X; Chang HC; Wang Y
    ACS Nano; 2023 Jun; 17(11):10191-10205. PubMed ID: 37127891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
    Geng T; Leung E; Chamley LW; Wu Z
    Biomater Adv; 2023 Jun; 149():213388. PubMed ID: 37003022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Milk-Derived Small Extracellular Vesicles and Their Biomedical Applications.
    Zhong Y; Wang X; Zhao X; Shen J; Wu X; Gao P; Yang P; Chen J; An W
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion with ARRDC1 or CD63: A Strategy to Enhance p53 Loading into Extracellular Vesicles for Tumor Suppression.
    Liu M; Zhang Y; He J; Liu W; Li Z; Zhang Y; Gu A; Zhao M; Liu M; Liu X
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer.
    Zhang W; Ngo L; Tsao SC; Liu D; Wang Y
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16420-16433. PubMed ID: 36961985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA.
    McCann J; Sosa-Miranda CD; Guo H; Reshke R; Savard A; Zardini Buzatto A; Taylor JA; Li L; Gibbings DJ
    J Extracell Vesicles; 2022 Oct; 11(10):e12220. PubMed ID: 36214496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward.
    Zhang YF; Shi JB; Li C
    Cytotherapy; 2019 Nov; 21(11):1122-1136. PubMed ID: 31699595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized Blood Small Extracellular Vesicles with Polydopamine Nanoparticles for Chemo-Thermal Therapy.
    Hu C; Dai S; Zhao X; Tang R; Shan P; Wang Y; Li P; Wang S; Zhou Q; Qi H
    ACS Appl Mater Interfaces; 2024 Jul; 16(27):34561-34577. PubMed ID: 38919091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Labeling Approaches Used in Small Extracellular Vesicles Tracing and Imaging.
    Bao C; Xiang H; Chen Q; Zhao Y; Gao Q; Huang F; Mao L
    Int J Nanomedicine; 2023; 18():4567-4588. PubMed ID: 37588627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single vesicle analysis reveals the release of tetraspanin positive extracellular vesicles into circulation with high intensity intermittent exercise.
    McIlvenna LC; Parker HJ; Seabright AP; Sale B; Anghileri G; Weaver SRC; Lucas SJE; Whitham M
    J Physiol; 2023 Nov; 601(22):5093-5106. PubMed ID: 36855276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.